Huimei Capital
Beijing, Beijinghuimeicap.com
Overview
Huimei Capital is an early and growth stage venture capital firm that focuses on investing in the healthcare sector . It was co-founded by Hillhouse Capital and Mayo Clinic . The firm is committed to building an investment platform with a global view and local execution to help early and growth-stage healthcare companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Shanghai LePure Biotechnology Co., Ltd. | Jan 2023 | Series C | Co-investor |
| Shanghai LePure Biotechnology Co., Ltd. | Nov 2022 | Strategic | Co-investor |
| Sichuan Jinjiang Electronic Medical Device Technology Co., Ltd. | Aug 2022 | Series B | Co-investor |
| Beijing Yibai Technology | Apr 2022 | Series B | Lead |
| Shandong Yingsheng Biotechnology Co., Ltd. | Mar 2022 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
